ClinicalTrials.Veeva

Menu

Antioxidant Supplementation in Trauma Patients

Boston Medical Center (BMC) logo

Boston Medical Center (BMC)

Status and phase

Terminated
Phase 3

Conditions

Multiple Trauma

Treatments

Dietary Supplement: powdered cornstarch placebo
Dietary Supplement: powdered antioxidant

Study type

Interventional

Funder types

Other

Identifiers

NCT00613392
H-25038

Details and patient eligibility

About

Administration of antioxidants to trauma patients will improve measures of oxidant stress in the blood

Enrollment

18 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult non pregnant non lactating trauma patient

Exclusion criteria

  • GCS <6
  • Renal dysfunction (cre > 2.5 mg/dl)
  • Hepatic dysfunction ( TBili > 3.0 mg/dl)
  • Expected survival < 48 hours
  • Burns over > 20% body surface area
  • Immune-deficiency syndromes
  • Steroid use

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

18 participants in 2 patient groups, including a placebo group

1
Experimental group
Treatment:
Dietary Supplement: powdered antioxidant
2
Placebo Comparator group
Treatment:
Dietary Supplement: powdered cornstarch placebo

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems